Ambagon Therapeutics
PrivateLast Round
Series A
Jan 6, 2022
Total Funding Raised
$103M
Company Overview
Ambagon Therapeutics is a biotechnology company that develops small-molecule cancer drugs by stabilizing the interaction of 14-3-3 proteins with oncogenic client proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ambagon Therapeutics Comparables
Compare Ambagon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Magnet Biomedicine | 92% | |
| Plexium | 89% | |
| SEED Therapeutics | 88% |
Ambagon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 6, 2022 | ||||
| Seed | Jul 1, 2020 |
Ambagon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series A |
| RA Capital Management | Series A, Seed |
| Droia Ventures | Seed, Series A |
| BioInnovation Capital | Series A |
| AbbVie Ventures | Seed, Series A |
| Citadel | Series A |
| Inkef Capital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2022
$85M round led by Nextech Invest.
- Jul 1, 2020
$18M round led by RA Capital Management.
Ambagon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ambagon Therapeutics's valuation, stock price, and market status.
Is Ambagon a public or private company?
Ambagon is a private company.
What is the current stock price of Ambagon?
Ambagon is a private company with no public stock price. No recent secondary market data is available.
How much is Ambagon worth (valuation)?
Valuation information for Ambagon is not publicly available.
Can I buy Ambagon stock?
Ambagon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ambagon's last funding round?
Ambagon's most recent funding round was Series A on January 6, 2022.
Who are the main investors in Ambagon?
Key investors in Ambagon include RA Capital Management, Nextech Invest.
Will Ambagon IPO soon?
No public IPO plans have been announced for Ambagon.
How can I track Ambagon secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ambagon's secondary market activity and sign up for updates.